PharmaShots | Incisive News in 3 Shots

Subscribe Now

Treatment-Resistant Depression

Janssen Files NDA for Esketamine Nasal Spray to the US for treatment-resistant depression

Janssen Files NDA for Esketamine Nasal Spray to the US for treatment-resistant depression

September 5, 2018

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us